|
English

Pr J. Selves
University Professor and Hospital Practitioner in Pathology
Toulouse, France
Summary
Years of experience : 26
Number of cases processed per year : > 300
Publications : 148
Networks :
TENPATH, Member
RenaPath, Member
Organizations :
SFP - Société Francaise de Pathologie, Member of the Administration Committee
Carrefour de Pathologie, Member of the Scientific Committee
FFCD, Member of the Scientific Committee
JFHOD, Member of the Scientific Committee
CHDH, Board Member and Scientific Leader
CoPath, Member
Diplomas
2010
Graduate of Research Management
1993
Board certification in Pathology
1992
MD in Pathology (Gold medal)
1992
Msc in Human Physiopathology & Immunology
1990
Msc in Cellular Biology and Pathology
Career path
2012 - Today
Coordinator of the Midi-Pyrénées genetics platform
IUCT Oncopole, Toulouse, France
2011 - Today
University Professor and Hospital Practitioner in Pathology
IUCT Oncopole, Toulouse, France
2010
Research study in Molecular markers and biotherapy of pancreatic cancer and hepatocellular carcinoma
INSERM U858-I2MR, Toulouse, France
1996 - 2011
University Lecturer and Hospital Practitioner in Pathology
Purpan Public Hospital, Toulouse, France
1992 - 1996
University Assistant Lecturer
Purpan Public Hospital, Toulouse, France
Advantages of referring cases to Pr J. Selves

The department of pathology from Toulouse/ Oncopole is the greater academic laboratory in France comprising more than 30 pathologists allowing the management of all specialties. This department includes several technological platforms: an immunohistochemistry platform (with more than 250 antibodies available), a platform of molecular pathology (FISH analysis, NGS sequencing, Sanger genotyping) and an imaging platform (with 2 scanners of slides).

Pr J Selves is in charge of the molecular platform where are performed 2000 analysis /years for GI cancers (colorectal cancer, GIST, gastric carcinoma, Lynch syndromes or liver tumors).

Her specific topics are cancerous or pre-cancerous lesions of GI tract, liver and pancreas, the identification of new molecular and immunohistochemistry markers useful in GI pathology, the identification of hereditary forms of GI cancers and the liver diseases.